Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Relmada Therapeutics Inc
NASDAQ:RLMD
Relmada Therapeutics Inc
NASDAQ:RLMD
Price:
3.83
USD
0.52%
Market Cap:
$401.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
Southern Co
NYSE:SO
|
US |
Wall St Price Targets
RLMD Price Forecast
Based on 7 analysts
Based on 7 analysts
+220% Upside
from
$3.83
today
Relmada Therapeutics Inc (RLMD)’s 12-month stock price forecast through September 2027 has a consensus target of $12.24, implying 220% upside. The forecast is based on price targets from 7 Wall Street analysts.
RLMD Analyst Rating
Based on 3 analysts
Based on 3 analysts
Analysts rate RLMD Hold, with 3 of 3 recommending Hold.
Relmada Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RLMD's stock price target?
Price Target
12.24
USD
12.24
USD
According to Wall Street analysts, the average 1-year price target for RLMD is 12.24 USD with a low forecast of 9.09 USD and a high forecast of 19.95 USD.